ELIS And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – ELIS (ELIS.PA), BASIC-FIT (BFIT.AS), AKER SOLUTIONS (AKSO.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ELIS (ELIS.PA)

77.2% sales growth and 9.02% return on equity

Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.

Earnings Per Share

As for profitability, ELIS has a trailing twelve months EPS of €1.19.

PE Ratio

ELIS has a trailing twelve months price to earnings ratio of 17.51. Meaning, the purchaser of the share is investing €17.51 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.02%.

Volume

Today’s last reported volume for ELIS is 48184 which is 81.85% below its average volume of 265597.

Yearly Top and Bottom Value

ELIS’s stock is valued at €20.84 at 01:20 EST, below its 52-week high of €21.12 and way higher than its 52-week low of €14.96.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 4.14B for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 0.41 and the estimated forward annual dividend yield is 1.96%.

More news about ELIS.

2. BASIC-FIT (BFIT.AS)

31.3% sales growth and 4.68% return on equity

Basic-Fit N.V., together with its subsidiaries, engages in the operation of fitness clubs. It operates 1200 clubs under Basic-Fit brand in Netherlands, Belgium, Luxembourg, Germany, France, and Spain. The company was founded in 1984 and is headquartered in Hoofddorp, the Netherlands.

Earnings Per Share

As for profitability, BASIC-FIT has a trailing twelve months EPS of €0.27.

PE Ratio

BASIC-FIT has a trailing twelve months price to earnings ratio of 99.85. Meaning, the purchaser of the share is investing €99.85 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.68%.

Sales Growth

BASIC-FIT’s sales growth is 31.3% for the present quarter and 31.3% for the next.

More news about BASIC-FIT.

3. AKER SOLUTIONS (AKSO.OL)

16.8% sales growth and 17.09% return on equity

Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry worldwide. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of deep-water risers, oil, and gas production, and receiving and processing facilities. In addition, the company provides offshore fish farming, carbon capture, utilization and storage, hydrogen, and offshore wind solutions. Further, the company designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides subsea production, compression, pump, power distribution, and processing systems, and subsea lifecycle services. Furthermore, the company offers maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.41.

PE Ratio

AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing kr10.5 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.

Moving Average

AKER SOLUTIONS’s worth is way below its 50-day moving average of kr42.31 and below its 200-day moving average of kr39.19.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 14, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 2.01%.

Volume

Today’s last reported volume for AKER SOLUTIONS is 731481 which is 22.29% below its average volume of 941336.

Revenue Growth

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 48.05B for the twelve trailing months.

More news about AKER SOLUTIONS.

4. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 16.03% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.5. Meaning, the purchaser of the share is investing kr23.5 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.

Moving Average

VISTIN PHARMA’s value is higher than its 50-day moving average of kr23.13 and higher than its 200-day moving average of kr23.02.

More news about VISTIN PHARMA.

Leave a Reply

Your email address will not be published. Required fields are marked *